Vasant Narasimhan Bio, Age, Family, Company, Salary, Net Worth, and Novartis

Vasant Narasimhan Photo
Vasant Narasimhan Photo

Originally published on famousintel.com

Vasant Narasimhan Biography and Wiki

Vasant Narasimhan is an Indian-American physician and the CEO of Novartis. He is the CEO of a business with about 100 000 employees that operate in more than 150 nations and provided medicines to 766 million patients in 2021.

Vasant Narasimhan Education

Narasimhan graduated from the University of Chicago with a bachelor’s degree in biological sciences, from Harvard Medical School with a medical degree, and from the John F. Kennedy School of Government with a master’s degree in public policy.

Vasant Narasimhan Age and Birthday

Narasimhan is 46 years old as of 2022. He was born Vasant “Vas” Narasimhan on 26 August 1976 in Pittsburgh, Pennsylvania, United States. He celebrates his birthday on 26 August every year.

Vasant Narasimhan Nationality and Ethnicity

Is Vasant Narasimhan Indian? Narasimhan is of American nationality by birth. He was born in Pittsburgh, Pennsylvania, United States. He was born to Indian immigrants. READ ALSO: Oscar Munoz

Vasant Narasimhan Family

Narasimhan was born to Kalathur Narasimhan, and Gita Narasimhan. Former nuclear engineer for Public Service Electric & Gas, Gita Narasimhan, is now a physics lecturer at Burlington County Community College in Pemberton, New Jersey. In Cinnaminson, New Jersey, the Hoeganaes Corporation, a developer and supplier of industrial raw materials, employs his father as vice president for research and development.

Vasant Narasimhan Wife

Narasimhan is married to Srishi Gupta, a daughter of Dr. and Mrs. Jagdish K. Gupta of Roslyn, N.Y.. The couple married at Antun’s Catering in Hicksville, N.Y.

Vasant Narasimhan Height

Narasimhan stands at an average height of 6 feet 0 inches.

What is Novartis CEO’s Salary?

The CEO’s total realized salary in 2021 was CHF 11 224 727.

Vasant Narasimhan Net Worth

Narasimhan has an estimated net worth of $5 Million.

Vasant Narasimhan Novartis

After graduating from Harvard, Narasimhan joined McKinsey & Co, Inc. He was later approached by Novartis in 2005. He worked for Novartis Pharmaceuticals as the global head of development from 2014 to 2016. He served as the company’s Chief Medical Officer and Global Head of Drug Development from 2016 to 2018. He was chosen to succeed Joseph Jimenez as CEO of Novartis on September 5, 2017.

A multinational pharmaceutical company with offices in Basel, Switzerland, and Cambridge, Massachusetts, the United States, is known as Novartis AG (global research). The company is one of the biggest in the pharmaceutical industry. Clozapine (marketed as Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (marketed as Tegretol), valsartan (marketed as Diovan), imatinib mesylate (marketed as Gleevec/Glivec), cyclosporine (marketed as Neoral/Sandimmune), letrozole (marketed as Femara), methylpheni

The businesses Ciba-Geigy and Sandoz merged in order to create Novartis in March 1996. Novartis was created as an independent company by the companies’ pharmaceutical and agrochemical divisions. Similar to Ciba Specialty Chemicals, other Ciba-Geigy and Sandoz businesses were sold or spun off as separate businesses. After going extinct for three years, the Sandoz brand was brought back in 2003 when Novartis combined its generic drug businesses into a single subsidiary and gave it the name Sandoz.

READ MORE: Pat Gelsinger Bio, Age, Education, Wife, VMware, Christian, Net, Son Cancer, Intel CEO

In 2000, Novartis sold its agrochemical and genetically modified crop businesses when Syngenta was spun off in a joint venture with AstraZeneca, which had previously sold its agrochemical division. Novartis is a full member of the Pharmaceutical Research and Manufacturers of America (PhRMA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the European Federation of Pharmaceutical Industries and Associations (EFPIA)[5] (PhRMA).